Journal of the Egyptian National Cancer Institute. 1984; 1 (3): 57-62
in English
| IMEMR
| ID: emr-106131
ABSTRACT
Seventy-four patients with Hodgkin's disease, lymphomas, and breast cancer were treated with vindesine 3 mg - 3.5mg/ m/[2]/week iv. Complete, partial and mixed responses were encountered in 16 of 26 patients with Hodgkins disease, in 9 of 24 lymphoma patients, and partial response in 4 of 24 breast cancer patients. Mild to moderate degree of peripheral neuropathy was encountered in 46 patients. Mild leucopenia was seen in 12 patients. It is concluded that vindesine is efficacious in Hodgkin's disease and lymphomas, and is recommended for combination chemotherapy regimes
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Vindesine
/
Breast Neoplasms
/
Chemotherapy, Adjuvant
Limits:
Female
/
Humans
/
Male
Language:
English
Journal:
J. Egypt. Natl. Cancer Inst.
Year:
1984
Similar
MEDLINE
...
LILACS
LIS